Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations

INTRODUCTION: COVID-19 is a major health threat around the world causing hundreds of millions of infections and millions of deaths. There is a pressing global need for effective therapies. We hypothesized that leukotriene inhibitors (LTIs), that have been shown to lower IL6 and IL8 levels, may have...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkin, Peter L., Resendez, Skyler, Mullin, Sarah, Troen, Bruce R., Mammen, Manoj J., Chang, Shirley, Franklin, Gillian, McCray, Wilmon, Brown, Steven H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274389/
https://www.ncbi.nlm.nih.gov/pubmed/35836784
http://dx.doi.org/10.1017/cts.2022.401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274389/
https://www.ncbi.nlm.nih.gov/pubmed/35836784
http://dx.doi.org/10.1017/cts.2022.401

Ejemplares similares